Our Rare Disease Sales Compensation Solutions
Rare disease markets require compensation strategies that adapt to evolving commercial objectives, from launch through ongoing commercialization.
Educate not just on product, but rare disease & its diagnosis
Ensure as many prescribers try the product as possible
Keep the sales force motivated despite forecasting difficulty
Push maintenance in addition to prospecting & education
Mitigate volume differences across territories/plan periods
Keep all territories engaged no matter their volume
Common Rare Disease Pain Points We Solve
Lack of Data/Proxies
Developing plans without market data or proxies with which to gauge expectations
Territory Size
Small sales force services many HCPs due to often complex road to diagnosis
Forecasting Difficulty
Forecast being off by a few patients can result in the national goal being missed
Sales Force Disengagement
Sales force often disengages when sales fall below expectations
Emphasis on Education
Sales force must not only provide education on product, but also disease & diagnosis
Objective Effectiveness
It is often difficult to ensure non-sales objectives are measurable & impactful
Rewarding Inefficient Calls
Sales force often over-calls existing prescribers rather than prospecting new ones
Payout Inequities
Low volume reps disengage due to large differences in pay versus high volume peers
Rare Disease
Expertise
What Sets Us Apart?
Decades of Experience. Measurable Results.
Proprietary
SCOR³ES® Diagnostic
Design
Customization
Proven
Results
How Effective is your Current Sales Compensation Plan?
Answer a few questions to see how your sales compensation strategy compares to best practices in the life science industry.
Clients We’ve Served
Join the companies that have revolutionized their sales compensation and sales optimization strategy with The Marketing Advantage, from small start-ups to multi-national corporations.
Rare Disease Sales Compensation Resources
Partner with Rare Disease Compensation Experts
From launch preparation through ongoing commercialization, TMA helps rare disease organizations design compensation plans that motivate the right behaviors, adapt to changing objectives, and support sustainable growth.